About Terumo Neuro
Terumo Neuro is a Healthcare company based in Aliso Viejo (United States) founded in 1997. It provides medical devices for hemorrhagic and ischemic stroke care worldwide. It operates on a B2B model. Terumo Neuro offers products and services including Aspiration Catheters, Stentrievers, and Access Catheters. Its focus areas include Medical Devices, Neurovascular and Stroke Treatment. Its legal entity is MicroVention, Inc. Its competitors include Rapid Medical, Fluid Biomed, Cerus Endovascular, Oxford Endovascular and Anaconda Biomed and 4 more; 8 of its 9 listed competitors have raised funding.
Company details
Terumo Neuro, a subsidiary of Terumo Corporation, focuses on innovating neurovascular solutions for treating and preventing strokes through devices like catheters and stents. They offer products for hemorrhagic, ischemic, and access needs, supported by clinical data. Based primarily in Aliso Viejo, California, USA, the company serves healthcare professionals globally with a commitment to improving patient outcomes and advancing medical technology.
- Headquarters Aliso Viejo, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website terumoneuro.com
- Social LinkedIn X Instagram YouTube
- Legal Name Microvention, Inc.
Products & Services of Terumo Neuro
Terumo Neuro offers a comprehensive portfolio of products and services, including Aspiration Catheters, Stentrievers, and Access Catheters.
Devices for removing blood clots in ischemic stroke treatment
Tools for clot retrieval and revascularization in stroke cases
Products enabling access to treatment areas for neurovascular procedures
Apps and channels of Terumo Neuro
its YouTube channel Terumo Neuro has 1.63K subscribers and 30 videos.
Videos from Terumo Neuro
The most watched videos on Terumo Neuro's YouTube channel, Terumo Neuro (1.63K subscribers). Click a video to play it here.
More on Terumo Neuro.
People of Terumo Neuro
28 people are tracked at Terumo Neuro (15 in leadership, 13 in team).
| Name | Role | Group |
|---|---|---|
Becca Bonwit | Director, Clinical Science And Data Integrity | Leadership |
Thierry De Bosson | Chief Commercial Officer | Leadership |
Carsten Schroeder | President & CEO | Leadership |
Kristin Machacek Leary | Chief People Officer | Leadership |
Terrence Callahan | Sr. Director Post Market Surveillance | Leadership |
Robert Gash | Sr. Director - Clinical Research & Operations (us And China) | Leadership |
Colin Kavanagh | Executive Vice President Of Operations | Leadership |
Laura Schiesl Vega | Associate General Counsel & Senior Director, Legal Affairs | Leadership |
Michelle Wetherby | Director Clinical Research And Operations | Leadership |
Patricia Sanchez | Senior Director, Human Resources | Leadership |
Dwayne Bess | Director Of Commercial Excellence | Leadership |
Doug Fauth | Sr. Director, Global Talent Acquisition & Development | Leadership |
Filipe Santos | Marketing Director - EMEA | Leadership |
James Marquis | Marketing Director | Leadership |
Alessandra Spina | Chief Compliance Officer | Leadership |
Wes L. | Senior Territory Sales Manager | Team |
Frank Louro | Market Development Manager | Team |
Tim Bowden | Territory Sales Manager | Team |
Jacqueline Collins | General Counsel | Team |
Nagesh Uppuluri | SVP, Global Clinical & Medical Affairs | Team |
8 more people are available in the full profile.
Complete people profiles for Terumo Neuro
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Terumo Neuro
Terumo Neuro has 9 listed competitors in our database, 8 of them funded. They include Rapid Medical, Fluid Biomed, Cerus Endovascular, Oxford Endovascular and Anaconda Biomed, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rapid-medical.com | 2008 | Yokneam Illit, Israel | $79M | – | Neurovascular interventional devices including distal access catheters are developed. | |
| fluidbiomed.com | 2012 | Calgary, Canada | $32.55M | 49 | A hybrid polymer-metal stent for brain aneurysms is developed. | |
| cerusendo.com | 2011 | Oxford, United Kingdom | $8.21M | 14 | Interventional neuroradiology devices are developed for minimally invasive aneurysm treatment. | |
| oxfordendovascular.com | 2015 | Oxford, United Kingdom | $22.72M | 7 | Metallic mesh devices for brain aneurysms are developed. | |
| anaconda.bio | 2015 | Barcelona, Spain | $38.96M | – | Medical devices for mechanical thromboectomy and clot removal are developed. | |
| coaxia.com | 1999 | Maple Grove, United States | $72.6M | – | Catheter-based treatment for cerebral ischemia | |
| microvention.com | 1997 | Tustin, United States | – | – | Neuroendovascular technologies for cerebral and peripheral vascular diseases are developed. | |
| concentric-medical.com | 1999 | Mountain View, United States | $39.92M | – | Endovascular devices are manufactured for removing clots in ischemic stroke. | |
| sequentmedical.com | 2007 | Aliso Viejo, United States | $65.26M | 1,028 | Catheter-based neurovascular devices for aneurysm treatment are developed. |
Detailed competitors of Terumo Neuro
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Terumo Neuro
Websites that share an audience with Terumo Neuro (terumoneuro.com).
Websites whose visitors overlap most with Terumo Neuro. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| terumo.co.jp | 85% | 209.4K | #168,430 | View details | |
| terumo.com | 68% | 83.8K | #425,995 | View details |
Top companies in Neurology
10 companies that operate in the same segment as Terumo Neuro (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | 541 | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Terumo Neuro
Complete news archive for Terumo Neuro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Terumo Neuro
Terumo Neuro was founded in 1997.
Terumo Neuro is headquartered in Aliso Viejo, United States. It is registered at Aliso Viejo, California, United States.
Terumo Neuro, a subsidiary of Terumo Corporation, focuses on innovating neurovascular solutions for treating and preventing strokes through devices like catheters and stents. They offer products for hemorrhagic, ischemic, and access needs, supported by clinical data. Based primarily in Aliso Viejo, California, USA, the company serves healthcare professionals globally with a commitment to improving patient outcomes and advancing medical technology.
Terumo Neuro's top competitors include Rapid Medical, Fluid Biomed and Anaconda Biomed.
Terumo Neuro offers Aspiration Catheters, Stentrievers, and Access Catheters.
Terumo Neuro operates through Microvention, Inc..